Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

John Thomas Potts Jr., M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R13AR044475 (POTTS, JOHN T) Jan 1, 1997 - Dec 31, 1997
    Role: Principal Investigator
  2. K12DK001410 (POTTS, JOHN T) Jul 1, 1985 - Jun 30, 1998
    Role: Principal Investigator
  3. K12AM001410 (POTTS, JOHN T) Jul 1, 1985 - Jun 30, 1990
    Role: Principal Investigator
  4. P01DK011794 (POTTS, JOHN T) Jan 1, 1979 - Jun 30, 2024
    Hormonal Control of Calcium Metabolism
    Role: Principal Investigator
  5. P01AM011794 (POTTS, JOHN T) Jan 1, 1979 - Jul 31, 1988
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Noda H, Okazaki M, Joyashiki E, Tamura T, Kawabe Y, Khatri A, Jueppner H, Potts JT, Gardella TJ, Shimizu M. Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long-Acting PTH Analog (LA-PTH). JBMR Plus. 2020 Jul; 4(7):e10367. PMID: 32666018.
    Citations: 1     
  2. Noda H, Guo J, Khatri A, Dean T, Reyes M, Armanini M, Brooks DJ, Martins JS, Schipani E, Bouxsein ML, Demay MB, Potts JT, Jüppner H, Gardella TJ. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia. J Bone Miner Res. 2020 03; 35(3):540-549. PMID: 31693237.
    Citations:    Fields:    
  3. Martin TJ, Clemens TL, Compston JE, Potts JT, Thakker RV. Jeffrey Lima Hayes O'Riordan: March 27, 1931 - October 9, 2017. J Bone Miner Res. 2018 Jan; 33(1):1-2. PMID: 29194768.
    Citations:    Fields:    
  4. Guo J, Khatri A, Maeda A, Potts JT, Jüppner H, Gardella TJ. Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment. J Bone Miner Res. 2017 01; 32(1):86-98. PMID: 27428040.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  5. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT, Brandi ML, Bilezikian JP. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017 01; 28(1):1-19. PMID: 27613721.
    Citations: 66     Fields:    Translation:Humans
  6. Shimizu M, Joyashiki E, Noda H, Watanabe T, Okazaki M, Nagayasu M, Adachi K, Tamura T, Potts JT, Gardella TJ, Kawabe Y. Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys. J Bone Miner Res. 2016 07; 31(7):1405-12. PMID: 26865415.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  7. Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT. Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab. 2016 Jun; 101(6):2273-83. PMID: 26943719.
    Citations: 49     Fields:    Translation:Humans
  8. Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT. Management of Hypoparathyroidism: Present and Future. J Clin Endocrinol Metab. 2016 Jun; 101(6):2313-24. PMID: 26938200.
    Citations: 24     Fields:    Translation:Humans
  9. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct; 99(10):3561-9. PMID: 25162665.
    Citations: 189     Fields:    Translation:Humans
  10. Potts JT. A conversation with John T. Potts Jr. Interview by Ushma S. Neill. J Clin Invest. 2013 Nov; 123(11):4544-5. PMID: 24177463.
    Citations:    Fields:    Translation:HumansAnimals
  11. Potts JT. Acceptance remarks. J Clin Invest. 2013 Nov; 123(11):4977-8. PMID: 24177470.
    Citations:    Fields:    Translation:Humans
  12. Maeda A, Okazaki M, Baron DM, Dean T, Khatri A, Mahon M, Segawa H, Abou-Samra AB, Jüppner H, Bloch KD, Potts JT, Gardella TJ. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc Natl Acad Sci U S A. 2013 Apr 09; 110(15):5864-9. PMID: 23533279.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  13. Khan AA, Brandi ML, Potts JT, Bilezikian JP. Supplement on primary hyperparathyroidism. J Clin Densitom. 2013 Jan-Mar; 16(1):3. PMID: 23294731.